Article Text
Perspectives
The case for the WHO Advisory Note, Global Nicotine Reduction Strategy
Statistics from Altmetric.com
Footnotes
Funding US National Cancer Institute (U19CA157345) and National Institute on Drug Abuse (U54DA031659).
Disclaimer DKH and GZ are members of the WHO Study Group on Tobacco Product Regulation. The content of this commentary are solely the responsibility of the authors and represent the official views of neither the WHO nor the US National Institutes of Health nor the Food and Drug Administration.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.